相关实验视频

Updated: May 8, 2025

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

抗击Helicobacter pylori:专注于纳米材料的研究

Xuanping Wang¹, Xihui Felicia Chan², Yuyo Go³

¹Geriatric Department, Royal Victoria Hospital, Belfast, UK.

|December 26, 2024

概括

纳米材料显示出作为对抗Helicobacter pylori (H. pylori) 感染的非抗生素治疗方法的希望. 进一步的研究可能会导致消除H. pylori和打击抗生素耐药性的新策略.

科学领域:

生物医学工程生物医学工程
材料科学材料科学材料科学
传染性疾病传染性疾病

背景情况:

抗生素耐药性,特别是来自Helicobacter pylori (H. pylori) 感染的抗生素耐药性,需要新的抗菌战略.
纳米材料为开发针对H.pylori的非抗生素治疗提供了一个有希望的途径.

研究的目的:

审查纳米材料在非抗生素抗H. pylori治疗策略中的进展.
探索基于纳米材料的H. pylori向,刺激响应释放和多功能平台的进展.

主要方法:

对金属和非金属纳米粒子,纳米酶和多功能纳米平台的审查.
纳米材料集成与物理方法 (光,热,超声,磁性) 的分析.
关于直接抑制H. pylori和向传递的研究摘要.

主要成果:

金属和非金属纳米颗粒和纳米酶表明直接抑制H. pylori的生长.
纳米材料使得有针对性的输送和刺激反应释放在胃中成为可能.
多功能纳米平台在与物理方法相结合时,协同增强H. pylori治疗.

结论:

纳米材料为抗生素提供了可行的替代方案,用于根除H. pylori.
对纳米平台的持续研究具有对抗H. pylori感染和抗生素耐药性的巨大潜力.

关键词:

在Helicobacter Pylori的研究中,纳米材料的使用方法不使用抗生素的策略.治疗治疗治疗治疗治疗治疗

更多相关视频

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

相关概念视频

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...